Francisco Diaz-Mitoma
2020
In 2020, Francisco Diaz-Mitoma earned a total compensation of $1.2M as Chief Medical Officer at VBI Vaccines, a 33% increase compared to previous year.
Compensation breakdown
| Bonus | $95,117 |
|---|---|
| Option Awards | $731,708 |
| Salary | $396,292 |
| Total | $1,223,117 |
Diaz-Mitoma received $731.7K in option awards, accounting for 60% of the total pay in 2020.
Diaz-Mitoma also received $95.1K in bonus and $396.3K in salary.
Rankings
In 2020, Francisco Diaz-Mitoma's compensation ranked 7,752nd out of 13,090 executives tracked by ExecPay. In other words, Diaz-Mitoma earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,752 out of 13,090 | 41st |
Division Manufacturing | 3,270 out of 5,618 | 42nd |
Major group Chemicals And Allied Products | 1,326 out of 2,251 | 41st |
Industry group Drugs | 1,149 out of 1,951 | 41st |
Industry Pharmaceutical Preparations | 854 out of 1,456 | 41st |
Source: SEC filing on April 26, 2021.
Diaz-Mitoma's colleagues
We found two more compensation records of executives who worked with Francisco Diaz-Mitoma at VBI Vaccines in 2020.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019